Correction to: Intermittent levosimendan infusion in ambulatory patients with end-stage heart failure: a systematic review and meta-analysis of 984 patients (Heart Failure Reviews, (2021), 10.1007/s10741-021-10101-0)

Hagar Elsherbini, Osama Soliman*, Casper Zijderhand, Mattie Lenzen, Sanne E. Hoeks, Rasha Kaddoura, Mohamed Izham, Abdulaziz Alkhulaifi, Amr S. Omar, Kadir Caliskan*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorPopular

5 Downloads (Pure)

Abstract

The article “Intermittent levosimendan infusion in ambulatory patients with end‑stage heart failure: a systematic review and meta‑analysis of 984 patients”, written by Hagar Elsherbini, Osama Soliman, Casper Zijderhand, Mattie Lenzen, Sanne E. Hoeks, Rasha Kaddoura, Mohamed Izham5, Abdulaziz Alkhulaifi, Amr S. Omar, and Kadir Caliskan, was originally published electronically on the publisher’s internet portal on 11 April 2021 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 10 June 2021 to

Original languageEnglish
Pages (from-to)1525
Number of pages1
JournalHeart Failure Reviews
Volume26
Issue number6
Early online date21 Jun 2021
DOIs
Publication statusPublished - Nov 2021

Bibliographical note

Publisher Copyright:
© 2021, The Author(s).

Fingerprint

Dive into the research topics of 'Correction to: Intermittent levosimendan infusion in ambulatory patients with end-stage heart failure: a systematic review and meta-analysis of 984 patients (Heart Failure Reviews, (2021), 10.1007/s10741-021-10101-0)'. Together they form a unique fingerprint.

Cite this